eledoisin [3181]



eledoisin


SMILES CC[C@H](C)[C@H](NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](C)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CO)NC(=O)[C@@H]1CCCN1C(=O)[C@@H]1CCC(=O)N1)C(=O)NCC(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCSC)C(N)=O
InChIKey AYLPVIWBPZMVSH-FCKMLYJASA-N
Sequence XPSKDAFIGLM
HELM PEPTIDE1{[Glp].P.S.K.D.A.F.I.G.L.M.[am]}$$$$

Chemical Properties

Hydrogen bond acceptors 16
Hydrogen bond donors 14
Rotatable bonds 36
Log P -3.560
Molecular weight (Da) 1187.6
Stereochemistry info partial


No bioactivity data available.

eledoisin


Drug properties

Molecular type Peptide
Physiological/Surrogate Surrogate
Approved drug Yes

Distribution across phases (no. indications)

Phase I 0
Phase II 0
Phase III 0
Phase IV 0


Compound is not listed as a drug.